期刊文献+

胃肠道肿瘤促红细胞生成素受体表达和肿瘤血管生成关系及意义

The Relationship between Expression of Erythropoietin Receptor and Neovascularization in Gastric Cancer and Colorectal Cancer
下载PDF
导出
摘要 目的研究胃肠道肿瘤患者的促红细胞生成素受体(Epo-R)表达及其与肿瘤血管生成的关系。方法应用免疫组化方法检测43例胃癌和38例结直肠癌患者的Epo-R的表达,同时检测肿瘤微血管密度(MVD),并分析与临床病理之间的关系。结果①81例MVD平均计数为(29.62±9.61)个,70例表达Epo-R(平均阳性率为39.98±25.01%);②MVD与Epo-R呈正相关(r=0.3514、t=3.3340、P<0.001);Epo-R阳性表达患者的MVD明显高于Epo-R阴性患者(t=2.9565、P<0.01);③MVD和Epo-R均与有无转移、分期、分化程度和肿块大小均无关(均为P>0.05)。结论胃癌和结直肠癌患者高表达Epo-R,并与MVD呈正相关关系。MVD和Epo-R均与临床病理特征之间无明确关系。 Objective To study erythropoietin receptor(Epo - R) expression in gastric cancer and colorectal cancer and its relationship with neovascularization. Methords The expression of Epo - R and microvascular ensity(MVD) was detected by immunohistochemistry for 81 patients with gastric cancer and colorectal cancer. Results ①The rate of MVD and Epo - R were (29.62 ± 9.61 ) % and (39.98 ± 25.01 ) % respectively ; ②The expression of Epo - R was positively correlation with the MVD ( r = 0. 3514, t = 3. 3340, P 〈 0. 001 ) ; MVD increased with the increase of Epo - R expression. ③The MVD and Epo - R were no significantly correlated with the metastasis,size, clinical staging and histological grade. Conclusion The expression of Epo - R in gastric cancer and colorectal cancer was correlation with MVD,but there was no significantly correlated with the metastasis,size, clinical staging and histological grade.
出处 《医学研究杂志》 2009年第7期70-72,共3页 Journal of Medical Research
关键词 胃癌 结直肠癌 促红细胞生成素受体(Epo—R) 微血管密度(MVD) Gastric cancer Colorectal cancer Erythropoietin receptor Microvascular density
  • 相关文献

参考文献11

  • 1刘小平,宋少柏,李岗,王殿军,赵海潞,韦立新.结直肠肿瘤微血管计数与临床病理的相关性[J].世界华人消化杂志,1999,7(1):37-39. 被引量:17
  • 2武变荣,李积德,郭振昌,骆玉霜,沈存芳.VEGF和MVD在乳腺疾病血管生成中的意义[J].青海医学院学报,2008,29(1):11-14. 被引量:15
  • 3李宏江,敬静,汪静,吕青,陈琳,赵扬冰.乳腺肿瘤中VEGF的表达和MVD分布[J].四川大学学报(医学版),2005,36(2):288-289. 被引量:20
  • 4Mohyeldin A, Lu H, Dalgard C,et al. Erythropoietin signalling promotes invasiveness of human head and neck squamous cell carcinoma. Neoplasia,2005,7(5 ) :537 - 543.
  • 5Phillips TM, Kim K, Vlashi E, et al. Effects of recombinant erythropoietin on breast cancer - initating cells. Neoplasia ,2007,6 ( 12 ) :1122 - 1129.
  • 6Lai SY,Childs EE,Xi S,et al. Erythropoiesis- mediated activation of JAK - STAT signaling contributes to celluar invasion in head and neck squamous cell carcinoma. Oncogene ,2005,24 ( 27 ) :4442 - 4448.
  • 7Sinclair AM, Rogers N, Busse L,et al. Erythropoietin receptor tan seription is neither elevated nor predictive of surface expression in human tumor ceils. Br J Cancer, 2008,98 ( 6 ) : 1059 - 1067.
  • 8Shannon AM, Bouchier - Hayes DJ, Condron CM, et al. Correction of anaemia through the use of darbepoetin alpha improves chemotherapeutic outcome in a murine model of Lewis lung carcinoma. Br J Cancer,2005,93 ( 2 ) : 224 - 232.
  • 9Dubsky P,Sevelda P,Jakesz R,et al. Anemia is a significant prognos- tic factor in loeal relapse - free survival of premenopausal primary breast cancer patients receiving adjuvant eyclophosphamide/methotrexate/5 -fluprouraeil chemotherapy. Clin Cancer Res,2008,14(7 ) : 2082 - 2087.
  • 10刘飞德,陈凛,李基业.胃癌组织促红细胞生成素受体表达与血管生成的关系及意义[J].中华普通外科杂志,2006,21(2):130-132. 被引量:2

二级参考文献42

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部